{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:27:39Z","timestamp":1792794459931,"version":"4.5.0"},"reference-count":123,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2020JDRC0018"],"award-info":[{"award-number":["2020JDRC0018"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","award":["LCYJ2019-8"],"award-info":[{"award-number":["LCYJ2019-8"]}],"id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81902779"],"award-info":[{"award-number":["81902779"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073000"],"award-info":[{"award-number":["82073000"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173326"],"award-info":[{"award-number":["82173326"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.bcp.2022.115039","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T18:56:13Z","timestamp":1650048973000},"page":"115039","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Advances of podophyllotoxin and its derivatives: Patterns and mechanisms"],"prefix":"10.1016","volume":"200","author":[{"given":"Rong-jia","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-yang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-hua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-ling","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-hua","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bcp.2022.115039_b0005","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3390\/biom11040603","article-title":"Podophyllotoxin: History, Recent Advances and Future Prospects","volume":"11","author":"Shah","year":"2021","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.bcp.2022.115039_b0010","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1039\/D0NP00041H","article-title":"Challenges and potential for improving the druggability of podophyllotoxin-derived drugs in cancer chemotherapy","volume":"38","author":"Zhao","year":"2021","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bcp.2022.115039_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112830","article-title":"Recent advances of podophyllotoxin\/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: An update (2010\u20132020)","volume":"208","author":"Xiao","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2022.115039_b0020","first-page":"6506","article-title":"Development of podophyllotoxin-loaded nanostructured lipid carriers for the treatment of condyloma acuminatum","volume":"17","author":"Gao","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"7","key":"10.1016\/j.bcp.2022.115039_b0025","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1021\/acs.nanolett.0c01973","article-title":"Dually Enzyme- and Acid-Triggered Self-Immolative Ketal Glycoside Nanoparticles for Effective Cancer Prodrug Monotherapy","volume":"20","author":"Yu","year":"2020","journal-title":"Nano Lett."},{"issue":"97","key":"10.1016\/j.bcp.2022.115039_b0030","doi-asserted-by":"crossref","first-page":"15321","DOI":"10.1039\/D0CC06387H","article-title":"Self-assembling peptide\u2013etoposide nanofibers for overcoming multidrug resistance","volume":"56","author":"Zhang","year":"2020","journal-title":"Chem. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2022.115039_b0035","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/10717544.2020.1716875","article-title":"Highly loaded deoxypodophyllotoxin nano-formulation delivered by methoxy polyethylene glycol-block-poly (D, L-lactide) micelles for efficient cancer therapy","volume":"27","author":"Zu","year":"2020","journal-title":"Drug Delivery"},{"issue":"1","key":"10.1016\/j.bcp.2022.115039_b0040","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1080\/10717544.2020.1837293","article-title":"Enhanced oral bioavailability of an etoposide multiple nanoemulsion incorporating a deoxycholic acid derivative-lipid complex","volume":"27","author":"Jha","year":"2020","journal-title":"Drug Deliv"},{"key":"10.1016\/j.bcp.2022.115039_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.709075","article-title":"Insight Into the Molecular Mechanism of Podophyllotoxin Derivatives as Anticancer Drugs","volume":"9","author":"Fan","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bcp.2022.115039_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.110275","article-title":"Advanced nanoscale carrier-based approaches to overcome biopharmaceutical issues associated with anticancer drug \u2018Etoposide\u2019","volume":"106","author":"Choudhury","year":"2020","journal-title":"Mater. Sci. Eng., C"},{"issue":"11","key":"10.1016\/j.bcp.2022.115039_b0055","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1021\/np980136z","article-title":"Antiviral activity of lignans","volume":"61","author":"Charlton","year":"1998","journal-title":"J. Nat. Prod."},{"issue":"5","key":"10.1016\/j.bcp.2022.115039_b0060","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.pharep.2017.04.007","article-title":"Deoxypodophyllotoxin induces cytoprotective autophagy against apoptosis via inhibition of PI3K\/AKT\/mTOR pathway in osteosarcoma U2OS cells","volume":"69","author":"Kim","year":"2017","journal-title":"Pharmacol. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2022.115039_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/med.21319","article-title":"Recent progress on C-4-modified podophyllotoxin analogs as potent antitumor agents","volume":"35","author":"Liu","year":"2015","journal-title":"Med. Res. Rev."},{"issue":"12","key":"10.1016\/j.bcp.2022.115039_b0070","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23123303","article-title":"Combined In Vitro Studies and in Silico Target Fishing for the Evaluation of the Biological Activities of Diphylleia cymosa and Podophyllum hexandrum","volume":"23","author":"Rocha","year":"2018","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.bcp.2022.115039_b0075","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","article-title":"Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study","volume":"5","author":"Abd-Allah","year":"2019","journal-title":"JAMA oncology"},{"issue":"1","key":"10.1016\/j.bcp.2022.115039_b0080","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/med.21377","article-title":"Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates","volume":"36","author":"Xiao","year":"2016","journal-title":"Med. Res. Rev."},{"issue":"10","key":"10.1016\/j.bcp.2022.115039_b0085","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0959-8049(98)00228-7","article-title":"Etoposide: four decades of development of a topoisomerase II inhibitor","volume":"34","author":"Hande","year":"1998","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2022.115039_b0090","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1080\/14756366.2020.1821676","article-title":"DNA topoisomerases as molecular targets for anticancer drugs","volume":"35","author":"Buzun","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2022.115039_b0095","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1200\/JCO.1999.17.2.569","article-title":"Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins","volume":"17","author":"Smith","year":"1999","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.bcp.2022.115039_b0100","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/rheumatology\/39.3.316","article-title":"A clinical study of CPH 82 vs methotrexate in early rheumatoid arthritis","volume":"39","author":"Lerndal","year":"2000","journal-title":"Rheumatology (Oxford)"},{"issue":"14","key":"10.1016\/j.bcp.2022.115039_b0105","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1021\/jm960023h","article-title":"San Feliciano, Immunosuppressive cyclolignans","volume":"39","author":"Gordaliza","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2022.115039_b0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-pathol-020117-043625","article-title":"Hemophagocytic Lymphohistiocytosis","volume":"13","author":"Al-Samkari","year":"2018","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.bcp.2022.115039_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114847","article-title":"The impact of DAMP-mediated inflammation in severe COVID-19 and related disorders","volume":"195","author":"Parthasarathy","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2022.115039_b0120","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.3389\/fimmu.2020.01445","article-title":"Potential Treatments for COVID-19 Related Cytokine Storm - Beyond Corticosteroids","volume":"11","author":"Miao","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2022.115039_b0125","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/SHK.0000000000001231","article-title":"Etoposide and Corticosteroid Combination Therapy Improves Acute Respiratory Distress Syndrome in Mice","volume":"52","author":"Aoyagi","year":"2019","journal-title":"Shock"},{"issue":"23","key":"10.1016\/j.bcp.2022.115039_b0130","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1182\/blood.2018894618","article-title":"Recommendations for the management of hemophagocytic lymphohistiocytosis in adults","volume":"133","author":"La Ros\u00e9e","year":"2019","journal-title":"Blood"},{"issue":"2021","key":"10.1016\/j.bcp.2022.115039_b0135","article-title":"Patients Using Combination Therapy With Etoposide and Corticosteroids","volume":"8","author":"Aoyagi","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.bcp.2022.115039_b0140","first-page":"1","article-title":"Plant-derived lignans as potential antiviral agents: a systematic review","author":"Xu","year":"2021","journal-title":"Phytochem. Rev."},{"issue":"3","key":"10.1016\/j.bcp.2022.115039_b0145","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/095632029800900307","article-title":"Inhibitory effects of podophyllotoxin derivatives on herpes simplex virus replication","volume":"9","author":"Sudo","year":"1998","journal-title":"Antivir Chem Chemother"},{"issue":"1","key":"10.1016\/j.bcp.2022.115039_b0150","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/bjd.18638","article-title":"Topically applied treatments for external genital warts in nonimmunocompromised patients: a systematic review and network meta-analysis","volume":"183","author":"Jung","year":"2020","journal-title":"Br. J. Dermatol."},{"issue":"5","key":"10.1016\/j.bcp.2022.115039_b0155","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3390\/jcm4050832","article-title":"Advancements in Pharmacotherapy for Noncancerous Manifestations of HPV","volume":"4","author":"Kollipara","year":"2015","journal-title":"J Clin Med"},{"issue":"24","key":"10.1016\/j.bcp.2022.115039_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20240","article-title":"Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluation","volume":"20","author":"Thurgar","year":"2016","journal-title":"Health Technol. Assess."},{"issue":"1","key":"10.1016\/j.bcp.2022.115039_b0165","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/1872213X11666170518114456","article-title":"Molluscum Contagiosum: An Update","volume":"11","author":"Leung","year":"2017","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"issue":"5","key":"10.1016\/j.bcp.2022.115039_b0170","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/bjh.15988","article-title":"Requirement for etoposide in the initial treatment of Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis","volume":"186","author":"Song","year":"2019","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.bcp.2022.115039_b0175","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/cid\/ciy044","article-title":"As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264\/AMC-067 Randomized Clinical Trial","volume":"67","author":"Hosseinipour","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bcp.2022.115039_b0180","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3389\/fimmu.2016.00206","article-title":"Multiple Targets of Salicylic Acid and Its Derivatives in Plants and Animals","volume":"7","author":"Klessig","year":"2016","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bcp.2022.115039_b0185","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of Cancer: The Next Generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bcp.2022.115039_b0190","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0163-7258(93)90044-E","article-title":"Podophyllotoxin, steganacin and combretastatin: natural products that bind at the colchicine site of tubulin","volume":"59","author":"Sackett","year":"1993","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2022.115039_b0195","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.bbrc.2017.08.125","article-title":"Structure of 4\u2032-demethylepipodophyllotoxin in complex with tubulin provides a rationale for drug design","volume":"493","author":"Niu","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.bcp.2022.115039_b0200","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2174\/1568011054222364","article-title":"Etoposide, topoisomerase II and cancer","volume":"5","author":"Baldwin","year":"2005","journal-title":"Curr. Med. Chem. Anticancer Agents"},{"issue":"4","key":"10.1016\/j.bcp.2022.115039_b0205","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.molcel.2015.10.040","article-title":"Targeting the DNA Damage Response in Cancer","volume":"60","author":"O'Connor","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcp.2022.115039_b0210","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.600521","article-title":"Podophyllotoxin Exposure Causes Spindle Defects and DNA Damage-Induced Apoptosis in Mouse Fertilized Oocytes and Early Embryos","volume":"8","author":"Hu","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bcp.2022.115039_b0215","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.toxicon.2020.01.006","article-title":"Podophyllotoxin affects porcine oocyte maturation by inducing oxidative stress-mediated early apoptosis","volume":"176","author":"Jiang","year":"2020","journal-title":"Toxicon"},{"issue":"12","key":"10.1016\/j.bcp.2022.115039_b0220","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrc2536","article-title":"Insulin and insulin-like growth factor signalling in neoplasia","volume":"8","author":"Pollak","year":"2008","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.bcp.2022.115039_b0225","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1124\/mol.107.040014","article-title":"Insulin-Like Growth Factor Type-I Receptor-Dependent Phosphorylation of Extracellular Signal-Regulated Kinase 1\/2 but not Akt (Protein Kinase B) Can Be Induced by Picropodophyllin","volume":"73","author":"Vasilcanu","year":"2008","journal-title":"Mol. Pharmacol."},{"issue":"7","key":"10.1016\/j.bcp.2022.115039_b0230","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/abbs\/gmz055","article-title":"Picropodophyllin inhibits type I endometrial cancer cell proliferation via disruption of the PI3K\/Akt pathway","volume":"51","author":"Dong","year":"2019","journal-title":"Acta Biochim. Biophy. Sin."},{"issue":"17","key":"10.1016\/j.bcp.2022.115039_b0235","doi-asserted-by":"crossref","first-page":"23772","DOI":"10.18632\/oncotarget.8180","article-title":"Virtual screening-driven repositioning of etoposide as CD44 antagonist in breast cancer cells","volume":"7","author":"Aguirre-Alvarado","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.bcp.2022.115039_b0240","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.3390\/cancers13123096","article-title":"Distinct Characteristics and Clinical Outcomes to Predict the Emergence of MET Amplification in Patients with Non-Small Cell Lung Cancer Who Developed Resistance after Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors","volume":"13","author":"Ahn","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bcp.2022.115039_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153355","article-title":"Targeted inhibition of c-MET by podophyllotoxin promotes caspase-dependent apoptosis and suppresses cell growth in gefitinib-resistant non-small cell lung cancer cells","volume":"80","author":"Oh","year":"2021","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.bcp.2022.115039_b0250","doi-asserted-by":"crossref","first-page":"559","DOI":"10.4014\/jmb.2101.01029","article-title":"Deoxypodophyllotoxin Inhibits Cell Growth and Induces Apoptosis by Blocking EGFR and MET in Gefitinib-Resistant Non-Small Cell Lung Cancer","volume":"31","author":"Kim","year":"2021","journal-title":"J. Microbiol. Biotechnol."},{"issue":"4","key":"10.1016\/j.bcp.2022.115039_b0255","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10456-017-9562-9","article-title":"Tumor angiogenesis and vascular normalization: alternative therapeutic targets","volume":"20","author":"Viallard","year":"2017","journal-title":"Angiogenesis"},{"issue":"8","key":"10.1016\/j.bcp.2022.115039_b0260","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.biocel.2013.04.030","article-title":"Deoxypodophyllotoxin exerts both anti-angiogenic and vascular disrupting effects","volume":"45","author":"Jiang","year":"2013","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"issue":"1","key":"10.1016\/j.bcp.2022.115039_b0265","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1021\/acsnano.0c07132","article-title":"Sequential Treatment of Bioresponsive Nanoparticles Elicits Antiangiogenesis and Apoptosis and Synergizes with a CD40 Agonist for Antitumor Immunity","volume":"15","author":"Ling","year":"2021","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.bcp.2022.115039_b0270","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","article-title":"The molecular machinery of regulated cell death","volume":"29","author":"Tang","year":"2019","journal-title":"Cell Res."},{"issue":"5","key":"10.1016\/j.bcp.2022.115039_b0275","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1021\/acs.accounts.9b00600","article-title":"Dissecting Programmed Cell Death with Small Molecules","volume":"53","author":"Bai","year":"2020","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bcp.2022.115039_b0280","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ijbiomac.2016.11.053","article-title":"Manipulation of pH-Sensitive interactions between podophyllotoxin-chitosan for enhanced controlled drug release","volume":"95","author":"Chen","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"issue":"13","key":"10.1016\/j.bcp.2022.115039_b0285","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.3390\/ijms21134640","article-title":"Picropodophyllotoxin, an Epimer of Podophyllotoxin, Causes Apoptosis of Human Esophageal Squamous Cell Carcinoma Cells Through ROS-Mediated JNK\/P38 MAPK Pathways","volume":"21","author":"Kwak","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bcp.2022.115039_b0290","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2174\/1871520620999200730160952","article-title":"Derivatives of Deoxypodophyllotoxin Induce Apoptosis through Bcl-2\/Bax Proteins Expression","volume":"21","author":"Li","year":"2021","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.bcp.2022.115039_b0295","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.1c01572","article-title":"Targeting Regulated Cell Death with Pharmacological Small Molecules: An Update on Autophagy-Dependent Cell Death, Ferroptosis, and Necroptosis in Cancer","author":"Wu","year":"2022","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2022.115039_b0300","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcp.2022.115039_b0305","article-title":"Repurposing drugs in autophagy for the treatment of cancer: From bench to bedside","author":"Bu","year":"2021","journal-title":"Drug Discov Today"},{"issue":"6","key":"10.1016\/j.bcp.2022.115039_b0310","doi-asserted-by":"crossref","DOI":"10.3390\/cells10061466","article-title":"Etoposide Triggers Cellular Senescence by Inducing Multiple Centrosomes and Primary Cilia in Adrenocortical Tumor Cells","volume":"10","author":"Teng","year":"2021","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.bcp.2022.115039_b0315","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/s41422-018-0065-z","article-title":"DNA damage triggers tubular endoplasmic reticulum extension to promote apoptosis by facilitating ER-mitochondria signaling","volume":"28","author":"Zheng","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.bcp.2022.115039_b0320","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.3389\/fonc.2020.01570","article-title":"EI24 Inhibits Cell Proliferation and Drug Resistance of Esophageal Squamous Cell Carcinoma","volume":"10","author":"Duan","year":"2020","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.bcp.2022.115039_b0325","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s00018-019-03236-9","article-title":"EI24 tethers endoplasmic reticulum and mitochondria to regulate autophagy flux","volume":"77","author":"Yuan","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bcp.2022.115039_b0330","first-page":"652","article-title":"EI24, as a Component of Autophagy","volume":"9","author":"Hwang","year":"2019","journal-title":"Is Involved in Pancreatic Cell Proliferation, Front Oncol"},{"issue":"5","key":"10.1016\/j.bcp.2022.115039_b0335","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/cdd.2016.8","article-title":"Cancer therapy in the necroptosis era","volume":"23","author":"Su","year":"2016","journal-title":"Cell Death Differ."},{"issue":"8","key":"10.1016\/j.bcp.2022.115039_b0340","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.biopha.2013.06.002","article-title":"Deoxypodophyllotoxin triggers necroptosis in human non-small cell lung cancer NCI-H460 cells","volume":"67","author":"Wu","year":"2013","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2022.115039_b0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108714","article-title":"Extracellular HMGB1 prevents necroptosis in acute myeloid leukemia cells","volume":"112","author":"Liu","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"6294","key":"10.1016\/j.bcp.2022.115039_b0350","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1126\/science.aaf7865","article-title":"Chemical genetic discovery of PARP targets reveals a role for PARP-1 in transcription elongation","volume":"353","author":"Gibson","year":"2016","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bcp.2022.115039_b0355","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00018-021-04109-w","article-title":"The key players of parthanatos: opportunities for targeting multiple levels in the therapy of parthanatos-based pathogenesis","volume":"79","author":"Liu","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.bcp.2022.115039_b0360","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.canlet.2015.11.044","article-title":"Deoxypodophyllotoxin triggers parthanatos in glioma cells via induction of excessive ROS","volume":"371","author":"Ma","year":"2016","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.bcp.2022.115039_b0365","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s00204-018-2170-7","article-title":"Cell death mechanisms of the anti-cancer drug etoposide on human cardiomyocytes isolated from pluripotent stem cells","volume":"92","author":"Nemade","year":"2018","journal-title":"Arch. Toxicol."},{"issue":"Pt A","key":"10.1016\/j.bcp.2022.115039_b0370","article-title":"Topoisomerase 2 inhibitor etoposide promotes interleukin-10 production in LPS-induced macrophages via upregulating transcription factor Maf and activating PI3K\/Akt pathway","volume":"101","author":"Zhang","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"19","key":"10.1016\/j.bcp.2022.115039_b0375","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1182\/blood-2015-01-551622","article-title":"How I treat hemophagocytic lymphohistiocytosis in the adult patient","volume":"125","author":"Schram","year":"2015","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.bcp.2022.115039_b0380","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1182\/blood-2017-06-788349","article-title":"Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study","volume":"130","author":"Bergsten","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bcp.2022.115039_b0385","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4049\/jimmunol.1302282","article-title":"Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis","volume":"192","author":"Johnson","year":"2014","journal-title":"J. Immunol."},{"issue":"7\u20138","key":"10.1016\/j.bcp.2022.115039_b0390","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2119\/2008-00034.Klune","article-title":"HMGB1: endogenous danger signaling","volume":"14","author":"Klune","year":"2008","journal-title":"Mol. Med."},{"issue":"1","key":"10.1016\/j.bcp.2022.115039_b0395","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s10020-021-00308-0","article-title":"Therapeutic administration of etoposide coincides with reduced systemic HMGB1 levels in macrophage activation syndrome","volume":"27","author":"Palmblad","year":"2021","journal-title":"Mol. Med."},{"issue":"10223","key":"10.1016\/j.bcp.2022.115039_b0400","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan","volume":"395","author":"Huang","year":"2020","journal-title":"China, Lancet"},{"issue":"1","key":"10.1016\/j.bcp.2022.115039_b0405","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s12185-020-02888-9","article-title":"Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19","volume":"112","author":"Takami","year":"2020","journal-title":"Int. J. Hematol."},{"issue":"1","key":"10.1016\/j.bcp.2022.115039_b0410","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/s12885-020-06964-5","article-title":"Damage-associated molecular patterns (DAMPs) related to immunogenic cell death are differentially triggered by clinically relevant chemotherapeutics in lung adenocarcinoma cells","volume":"20","author":"Solari","year":"2020","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.bcp.2022.115039_b0415","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002722","article-title":"IGF1 receptor inhibition amplifies the effects of cancer drugs by autophagy and immune-dependent mechanisms","volume":"9","author":"Wu","year":"2021","journal-title":"J. ImmunoTher. Cancer"},{"key":"10.1016\/j.bcp.2022.115039_b0420","first-page":"1","article-title":"Autophagy induction by IGF1R inhibition with picropodophyllin and linsitinib","author":"Wu","year":"2021","journal-title":"Autophagy"},{"issue":"4","key":"10.1016\/j.bcp.2022.115039_b0425","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.toxicon.2004.05.008","article-title":"Podophyllotoxin: distribution, sources, applications and new cytotoxic derivatives","volume":"44","author":"Gordaliza","year":"2004","journal-title":"Toxicon"},{"issue":"1","key":"10.1016\/j.bcp.2022.115039_b0430","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/DAD.0000000000002050","article-title":"Podophyllotoxin Cytological Effects on the Epidermis in Condyloma Acuminatum","volume":"44","author":"Leung","year":"2022","journal-title":"Am. J. Dermatopathol."},{"issue":"10","key":"10.1016\/j.bcp.2022.115039_b0435","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1007\/s00018-009-8631-7","article-title":"The regulation of cell proliferation by the papillomavirus early proteins","volume":"66","author":"Hamid","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"issue":"10","key":"10.1016\/j.bcp.2022.115039_b0440","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1016\/j.bmc.2008.03.053","article-title":"Podophyllotoxin directly binds a hinge domain in E2 of HPV and inhibits an E2\/E7 interaction in vitro","volume":"16","author":"Saitoh","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bcp.2022.115039_b0445","doi-asserted-by":"crossref","first-page":"8367","DOI":"10.1038\/srep08367","article-title":"IER3 is a crucial mediator of TAp73beta-induced apoptosis in cervical cancer and confers etoposide sensitivity","volume":"5","author":"Jin","year":"2015","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bcp.2022.115039_b0450","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ni.2236","article-title":"SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates","volume":"13","author":"Lahouassa","year":"2012","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2022.115039_b0455","doi-asserted-by":"crossref","first-page":"50","DOI":"10.15252\/embj.201796880","article-title":"DNA damage induced by topoisomerase inhibitors activates SAMHD1 and blocks HIV-1 infection of macrophages","volume":"37","author":"Mlcochova","year":"2018","journal-title":"EMBO J."},{"issue":"10","key":"10.1016\/j.bcp.2022.115039_b0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101169","article-title":"Etoposide, an anticancer drug involved in therapy-related secondary leukemia: Enzymes at play","volume":"14","author":"Zhang","year":"2021","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bcp.2022.115039_b0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119602","article-title":"Layered double hydroxide eliminate embryotoxicity of chemotherapeutic drug through BMP-SMAD signaling pathway","volume":"230","author":"Wang","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.bcp.2022.115039_b0470","article-title":"In vivo and in vitro inhibition of SCLC by combining dual cancer-specific recombinant adenovirus with Etoposide","author":"Li","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"Suppl 3","key":"10.1016\/j.bcp.2022.115039_b0475","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2165\/00003495-199958003-00008","article-title":"Extended-schedule oral etoposide in selected neoplasms and overview of administration and scheduling issues","volume":"58","author":"Hainsworth","year":"1999","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.bcp.2022.115039_b0480","first-page":"Cd007941","article-title":"Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma","volume":"5","author":"Skoetz","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"issue":"9","key":"10.1016\/j.bcp.2022.115039_b0485","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12092645","article-title":"Adding PD-1\/PD-L1 Inhibitors to Chemotherapy for the First-Line Treatment of Extensive Stage Small Cell Lung Cancer (SCLC): A Meta-Analysis of Randomized Trials","volume":"12","author":"Facchinetti","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"18","key":"10.1016\/j.bcp.2022.115039_b0490","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s40265-018-1022-3","article-title":"Daunorubicin\/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia","volume":"78","author":"Blair","year":"2018","journal-title":"Drugs"},{"issue":"8","key":"10.1016\/j.bcp.2022.115039_b0495","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/jamaoncol.2016.4280","article-title":"Comparison of Concurrent Use of Thoracic Radiation With Either Carboplatin-Paclitaxel or Cisplatin-Etoposide for Patients With Stage III Non\u2013Small-Cell Lung Cancer","volume":"3","author":"Steuer","year":"2017","journal-title":"JAMA Oncology"},{"key":"10.1016\/j.bcp.2022.115039_b0500","first-page":"Jco2101639","article-title":"Radiation and Systemic Therapy for Limited-Stage Small-Cell Lung Cancer","author":"Bogart","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.bcp.2022.115039_b0505","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1021\/acsnano.7b07878","article-title":"Drug Combination Synergy in Worm-like Polymeric Micelles Improves Treatment Outcome for Small Cell and Non-Small Cell Lung Cancer","volume":"12","author":"Wan","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.bcp.2022.115039_b0510","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.actbio.2021.02.001","article-title":"Co-delivery of etoposide and cisplatin in dual-drug loaded nanoparticles synergistically improves chemoradiotherapy in non-small cell lung cancer models","volume":"124","author":"Zhang","year":"2021","journal-title":"Acta Biomater."},{"issue":"5","key":"10.1016\/j.bcp.2022.115039_b0515","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1158\/1078-0432.CCR-08-1587","article-title":"Preclinical studies of vorinostat (suberoylanilide hydroxamic acid) combined with cytosine arabinoside and etoposide for treatment of acute leukemias","volume":"15","author":"Shiozawa","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.bcp.2022.115039_b0520","first-page":"634","article-title":"Co-delivery of Vorinostat and Etoposide Via Disulfide Cross-Linked Biodegradable Polymeric Nanogels: Synthesis","volume":"19","author":"Kumar","year":"2018","journal-title":"Characterization, Biodegradation, and Anticancer Activity, AAPS PharmSciTech"},{"issue":"10","key":"10.1016\/j.bcp.2022.115039_b0525","doi-asserted-by":"crossref","first-page":"10655","DOI":"10.1021\/nn504210g","article-title":"Brain-penetrating nanoparticles improve paclitaxel efficacy in malignant glioma following local administration","volume":"8","author":"Nance","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.bcp.2022.115039_b0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104551","article-title":"Topoisomerase inhibitors: Pharmacology and emerging nanoscale delivery systems","volume":"151","author":"Dehshahri","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2022.115039_b0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120722","article-title":"Effect of Paclitaxel\/etoposide co-loaded polymeric nanoparticles on tumor size and survival rate in a rat model of glioblastoma","volume":"604","author":"Maleki","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.bcp.2022.115039_b0540","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ctrv.2014.01.001","article-title":"Retinoids and breast cancer: from basic studies to the clinic and back again","volume":"40","author":"Garattini","year":"2014","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.bcp.2022.115039_b0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.110997","article-title":"Co-Administration of Tretinoin Enhances the Anti-Cancer Efficacy of Etoposide via Tumor-Targeted Green Nano-Micelles","volume":"192","author":"Gaber","year":"2020","journal-title":"Colloids Surf. B"},{"issue":"8","key":"10.1016\/j.bcp.2022.115039_b0550","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.bmcl.2019.02.005","article-title":"GSH-responsive anti-mitotic cell penetrating peptide-linked podophyllotoxin conjugate for improving water solubility and targeted synergistic drug delivery","volume":"29","author":"Wen","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bcp.2022.115039_b0555","first-page":"220","article-title":"Carrier-free nanodrugs with efficient drug delivery and release for cancer therapy: From intrinsic physicochemical properties to external modification","volume":"8","author":"Mei","year":"2022","journal-title":"Bioact. Mater."},{"issue":"21","key":"10.1016\/j.bcp.2022.115039_b0560","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1002\/asia.201901070","article-title":"A Reduction-responsive Amphiphilic Methotrexate-Podophyllotoxin Conjugate for Targeted Chemotherapy","volume":"14","author":"Hou","year":"2019","journal-title":"Chemistry \u2013 An Asian Journal"},{"key":"10.1016\/j.bcp.2022.115039_b0565","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jconrel.2014.09.001","article-title":"Nanocarrier mediated delivery of siRNA\/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances","volume":"194","author":"Gandhi","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bcp.2022.115039_b0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114113","article-title":"RNAi-based therapeutics and tumor targeted delivery in cancer","volume":"182","author":"Kara","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"20","key":"10.1016\/j.bcp.2022.115039_b0575","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.7150\/thno.32416","article-title":"Co-delivery of VEGF siRNA and Etoposide for Enhanced Anti-angiogenesis and Anti-proliferation Effectvia Multi-functional Nanoparticles for Orthotopic Non-Small Cell Lung Cancer Treatment","volume":"9","author":"Li","year":"2019","journal-title":"Theranostics"},{"issue":"18","key":"10.1016\/j.bcp.2022.115039_b0580","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1111\/febs.14492","article-title":"NF-\u03baB signaling mechanisms in HTLV-1-induced adult T-cell leukemia\/lymphoma","volume":"285","author":"Harhaj","year":"2018","journal-title":"FEBS J."},{"issue":"6","key":"10.1016\/j.bcp.2022.115039_b0585","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3390\/nano11061582","article-title":"Targeting NF-\u03baB with Nanotherapy in a Mouse Model of Adult T-Cell Leukemia\/Lymphoma","volume":"11","author":"Rauch","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.bcp.2022.115039_b0590","article-title":"Advances in Anti-Tumor Treatments Targeting the CD47\/SIRP\u03b1 Axis","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.bcp.2022.115039_b0595","doi-asserted-by":"crossref","first-page":"2001853","DOI":"10.1002\/adhm.202001853","article-title":"Combinatory Delivery of Etoposide and siCD47 in a Lipid Polymer Hybrid Delays Lung Tumor Growth in an Experimental Melanoma Lung Metastatic Model","volume":"10","author":"Abdel Bar","year":"2021","journal-title":"Adv. Healthcare Mater."},{"issue":"3","key":"10.1016\/j.bcp.2022.115039_b0600","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s11030-021-10217-3","article-title":"Artificial intelligence to deep learning: machine intelligence approach for drug discovery","volume":"25","author":"Gupta","year":"2021","journal-title":"Mol Divers"},{"key":"10.1016\/j.bcp.2022.115039_b0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106055","article-title":"Polypharmacology: The science of multi-targeting molecules","volume":"176","author":"Kabir","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.bcp.2022.115039_b0610","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1021\/acsnano.9b08142","article-title":"Meta-Analysis of Nanoparticle Delivery to Tumors Using a Physiologically Based Pharmacokinetic Modeling and Simulation Approach","volume":"14","author":"Cheng","year":"2020","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.bcp.2022.115039_b0615","doi-asserted-by":"crossref","first-page":"817","DOI":"10.7150\/thno.67932","article-title":"Targeting regulated cell death in tumor nanomedicines","volume":"12","author":"Zeng","year":"2022","journal-title":"Theranostics"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222001332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222001332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:33:13Z","timestamp":1777386793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295222001332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":123,"alternative-id":["S0006295222001332"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115039","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances of podophyllotoxin and its derivatives: Patterns and mechanisms","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115039"}}